Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Follistatin-like 3 is a secreted glycoprotein of the follistatin-module-protein family. Additionally we are shipping FSTL3 Kits (34) and FSTL3 Proteins (9) and many more products for this protein.
Showing 10 out of 64 products:
FSTL3 KO lead to increased activin (show Actbeta Antibodies) signaling, enhancing alpha- to beta-cell transdifferentiation in mouse islets.
FSTL3 is a critical mediator of exercise-dependent bone formation
Data indicate that deletion of activin (show Actbeta Antibodies) antagonists follistatin-like-3 (FSTL3) results in hepatic steatosis
Suggest FSTL3 has a role in paracrine communication between cardiomyocytes and fibroblasts.
crucial roles for FSTL3 in limiting testis organ size and promoting age-related testicular regression
These findings link FSTL3 and TGFbeta (show TGFB1 Antibodies) ligand signaling and a novel subset of the synexpression group of genes to organ/tissue-specific regulatory pathways.
These results demonstrate that body composition and glucose homeostasis are differentially regulated by FST (show FST Antibodies) and FSTL3 and that their combined loss is associated with increased fat mass and insulin (show INS Antibodies) resistance despite elevated insulin (show INS Antibodies) production.
Fstl3 as a stress-induced regulator of hypertrophy that controls myocyte size via regulation of Smad (show SMAD1 Antibodies) signaling.
regulation and expression patterns of follistatin (show FST Antibodies) and FLRG differ; FLRG is distributed in spermatogenic cells of the testis, renal tubules, epithelial cells of the lung, and myocardium
review with emphasis on authors' works on paracrine and autocrine regulation in activities of Fst (show FST Antibodies) and Fstl3, regulation of gonadal development, and structural elements necessary for biological activities
FSTL3 expression in invasive breast cancer is inversely associated with tumor size and nuclear grade but it does not predict disease relapse in the short term.
Human renal dysfunction is the strongest independent predictor of FSTL3 serum concentrations in multivariate analyses.
The serum levels of IL-8 (show IL8 Antibodies), MIP-1 alpha (show CCL3 Antibodies), MIP-1 beta (show CCL4 Antibodies), MMP-8 (show MMP8 Antibodies), Resistin (show RETN Antibodies), FLRG, and BCAM (show BCAT2 Antibodies) were significantly higher in breast cancer patients, but LAP and TSH-beta (show TSHB Antibodies) levels were lower.
Elevated FSTL-3 concentrations were attributable to preeclampsia and were associated with increased likelihood of later developing preeclampsia, suggesting further study as a biomarker prior to clinically evident disease.
The elevation of Follistatin-like-3 was demonstrated in late second trimester of pregnancy destined to developing preeclampsia, suggesting its causal role in the pathogenesis and prediction of preeclampsia.
Resistance exercise resulted in a significant downregulation of MSTN (show MSTN Antibodies) and FBXO32 (show FBXO32 Antibodies) mRNA expression and a significant upregulation in FSTL3 and SMURF1 (show SMURF1 Antibodies) mRNA expression, and carbohydrate and protein feeding have little influence on the these markers expression.
Data suggest that serum levels of FSTL3 are higher in pre-eclampsia than in controls; placental expression of FSTL3 is also increased in pre-eclampsia compared with controls; no differences were observed between mild and severe pre-eclampsia.
After eccentric exercise, postmenopausal women not using hormone therapy (HT) expressed higher levels of follistatin-like protein 3 while postmenopausal women using HT showed a significant increased expression over controls.
Follistatin-like 3 is a secreted glycoprotein of the follistatin-module-protein family. It may have a role in leukemogenesis.
follistatin-like protein 3
, follistatin-related gene protein
, follistatin-related protein 3